Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Emily Dusa

Nurse Practitioner Toledo, OH Nurse Practitioner

NPI 1205495900 CMS profile 11164470

2940 N McCord Rd, Toledo, OH 43615

Open in the dashboard

General payments

$1,563

40 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Emily Dusa of Toledo, OH is reported in the CMS Open Payments database as having received $1,563 across 40 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $469 12
2024 General $395 10
2023 General $90 4
2022 General $201 6
2021 General $408 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Emily Dusa
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Emily Dusa were reported at $469. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Emily Dusa Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $408 $135 $40–$426 $132
2022 $201 $152 $48–$470 $149
2023 $90 $166 $54–$529 $160
2024 $395 $173 $55–$556 $164
2025 $469 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Atricure, Inc. $525 13 payments
  2. Abiomed $235 4 payments
  3. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $193 11 payments
  4. AstraZeneca Pharmaceuticals LP $136 2 payments
  5. Janssen Scientific Affairs, LLC $125 1 payment
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $99 1 payment
  7. Astellas Pharma US Inc $99 1 payment
  8. Edwards Lifesciences Corporation $35 1 payment
  9. Urgo Medical North America, LLC $28 1 payment
  10. Novartis Pharmaceuticals Corporation $22 1 payment
  11. Other $66 4 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,464 39 payments
  2. Education $99 1 payment
Products named General payments · program years 2021–2025
  1. SYNERGY ABLATION SYSTEM $525 13 payments
  2. LifeVest $193 11 payments
  3. XARELTO $125 1 payment
  4. FARXIGA $125 1 payment
  5. JARDIANCE $99 1 payment
  6. Impella $98 2 payments
  7. KONECT RESILIA $35 1 payment
  8. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $28 1 payment
  9. ENTRESTO $22 1 payment
  10. Vascepa $18 1 payment
  11. Other $48 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

391

Median for Nurse Practitioner: 389

Drug cost

$1,364

Median for Nurse Practitioner: $21,885

Branded share of claims

7.2%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 64 $229
Warfarin Sodium Generic 40 $218
Pantoprazole Sodium Generic 25 $166
Amiodarone Hcl Generic 25 $156
Metoprolol Tartrate Generic 46 $154
Atorvastatin Calcium Generic 31 $123
Potassium Chloride Generic 42 $103
Clopidogrel Clopidogrel Bisulfate Brand 15 $76
Furosemide Generic 63 $46
Carvedilol Generic 12 $45

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$1,970

Medicare's payments for the services billed

Medicare patients

35

Average age 73

Services billed

41

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 74%
Heart failure 54%
Arthritis 54%
Diabetes 49%
Chronic kidney disease 46%
Atrial fibrillation 40%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

40 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record